LONDON (Alliance News) - Destiny Pharma PLC said on Thursday it has appointed Shaun Claydon as its new finance chief after the departure of Chief Financial Officer Simon Sacerdoti.
Claydon, who was most recently at dermatology firm Creabilis as head of finance, will start his role immediately. Sacerdoti will remain until the end of 2018 to help with the handover and then stay on a consultancy basis.
Chairman Nigel Rudd commented: "On behalf of the board, I wish to express our gratitude to Simon for his valuable contribution to Destiny Pharma over the past three years, including being an integral member of the team to execute a successful IPO last year.
"We are pleased to welcome Shaun to Destiny Pharma. His broad and relevant biotechnology sector experience as both CFO and COO will prove invaluable to the company as we execute our clinical strategy and next stages of growth."
Shares were down 2.0% on Thursday at a price of 75.00 pence each.
Destiny Pharma. (DEST)